eStoreRx™
Online Supplement Dispensary
eStoreRx™ is an easy direct-to-patient ordering & fulfilment program for lifelong wellness.
For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional
eStoreRx™ is an easy direct-to-patient ordering & fulfilment program for lifelong wellness.
Biotics Research is proud to expand our commitment to education with the Wellness Unfiltered Pro Podcast. Each episode delves into key health topics and the clinical applications of our premier products. Through candid, insightful conversations, our team offers practical guidance to keep you informed and empowered as a healthcare professional.
November 21 2024
The protective association between dietary flavonoid intake and the risk of dementia has been the focus of yet another study; this one being published...
While PPIs are widely used to treat gastrointestinal illnesses, recent evidence suggests they may be related to cognitive decline. A group of German researchers conducted a prospective cohort study to examine the association between the use of PPIs and the risk of incident dementia in the elderly. They used observational data (from 2004-2011) from the largest German statutory health insurer. Their analysis of 73,679 participants (≥ 75 yrs.) concluded in November 2015. The association between PPI use and dementia was analyzed using time-dependent Cox regression, adjusted for potential confounding factors such as age, sex and polypharmacy. Researchers discovered that patients receiving regular PPI medication had a significantly increased risk of incident dementia compared with patients not receiving PPIs. The researchers concluded that the avoidance of PPI medication may prevent the development of dementia. This finding is supported by recent pharmacoepidemiological analyses on primary data, and is in line with mouse models in which the use of PPIs increased the levels of β-amyloid in the brains of mice.
Comm, W, et al. Association of Proton Pump Inhibitors with Risk of Dementia; A Pharmacoepidemikological Claims Data Analysis. JAMA Neurol. doi:10.1001/jamaneurol.2015.4791 Published online Feb 14, 201
Submit this form and you'll receive our latest news and updates.
*These statements have not been evaluated by the Food and Drug Administration. This product has not intended to diagnose, treat, cure, or prevent any disease.
© 2023 Biotics Research Corporation - All Rights Reserved
Submit your comment